TradeWorx’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

TradeWorx’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-4,731	Closed	-$205K	–	570
2013 Q4	$205K	Buy	+4,731	New	+$196K	0.09%	387

Other funds holding XBI

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

TradeWorx's XBI Position: Q1 2014 in Review

TradeWorx sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2014, closing a stake of 4,731 shares — an estimated $205K sold.

TradeWorx first reported a position in XBI in Q4 2013 and held it in 1 quarter. The position peaked at $205K in Q4 2013. 131 funds tracked by Wall St. Rank hold XBI as of Q1 2014.

TradeWorx reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2014 after selling out during the quarter.
TradeWorx sold 4,731 State Street SPDR S&P Biotech ETF shares in Q1 2014, an estimated $205K.
TradeWorx first reported a position in State Street SPDR S&P Biotech ETF in Q4 2013 and held it in 1 quarter.
TradeWorx's State Street SPDR S&P Biotech ETF position peaked at $205K in Q4 2013.
131 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2014.

Based on TradeWorx's 13F filing for Q1 2014, filed 2 Jun 2014.